Does Internal Mammary Node Irradiation Have Survival Benefit for Clinical Stage, II-III Breast Cancer Patients After Neoadjuvant Chemotherapy?

被引:0
|
作者
Kim, K. [1 ]
Noh, J. [2 ]
Kim, Y. [1 ]
Chang, J. [1 ]
Keum, K. [1 ]
Huh, S. [2 ]
Choi, D. [2 ]
Park, W. [2 ]
Suh, C. [1 ]
机构
[1] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiat Oncol, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea
关键词
D O I
10.1016/j.ijrobp.2014.05.670
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1026
引用
收藏
页码:S168 / S168
页数:1
相关论文
共 50 条
  • [31] Surgical aspects of induction chemotherapy in stage II-III breast cancer
    Terribile, D
    Masetti, R
    Marra, A
    Antinori, A
    Valentini, M
    Margaritora, S
    Nardone, L
    Scapati, AM
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1043 - 1043
  • [32] Long-term Survival Outcomes Following Internal Mammary Node Irradiation in Stage II-III Breast Cancer: Results of a Large Retrospective Study With 12-Year Follow-up
    Chang, Jee Suk
    Park, Won
    Kim, Yong Bae
    Lee, Ik Jae
    Keum, Ki Chang
    Lee, Chang Geol
    Choi, Doo Ho
    Suh, Chang-Ok
    Huh, Seung Jae
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (05): : 867 - 872
  • [33] Long-term Survival Outcomes Following Internal Mammary Node Irradiation in Stage II-III Breast Cancer: Results of a Large Retrospective Study With 13-year Follow-up
    Chang, J.
    Park, W.
    Lee, I.
    Kim, Y.
    Lee, C.
    Keum, K.
    Suh, C.
    Huh, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S112 - S112
  • [34] Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer
    Fowble, B
    Hanlon, A
    Freedman, G
    Nicolaou, N
    Hoffman, J
    Sigurdson, E
    Boraas, M
    Torosian, M
    Goldstein, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (04): : 883 - 894
  • [35] Benefit vs Harm of Internal Mammary Node Irradiation for Node-Positive Breast Cancer
    White, Julia
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (10): : 1277 - 1278
  • [36] Prognostic Significance of Internal Mammary Node Involvement in Patients With Clinical Stage IIIC Breast Cancer Who Received Neoadjuvant Chemotherapy, Surgery, and Radiation Therapy
    Noh, J.
    Kim, K.
    Park, W.
    Suh, C.
    Huh, S.
    Choi, D.
    Kim, Y.
    Keum, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S259 - S259
  • [37] Actual conversion rate from total mastectomy to breast conservation after neoadjuvant chemotherapy for stages II-III breast cancer patients
    Mo, H.
    Kim, Y.
    Rhu, J.
    Lee, K. H.
    Kim, T. Y.
    Im, S. A.
    Lee, E. S.
    Lee, H. B.
    Moon, H. G.
    Noh, D. Y.
    Han, W.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S80 - S80
  • [38] Low dose metronomic cyclophosphamide, methotrexate (LDCM) and aspirin for patients with residual disease after neoadjuvant chemotherapy for stage II-III breast cancer.
    Ninfea, Jose Ignacio Ruades
    Burdette-Radoux, Susan
    Melissa of Sands
    Rincon, Mercedes
    Levist, Jamie E.
    Holmes, Chris E.
    Wood, Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Pathologic complete response after neoadjuvant paclitaxel and carboplatin chemotherapy for stage II-III breast cancer: A community cancer center experience.
    Belur, Anuradha
    Raajasekar, Arun Kumar Arumugam
    Burdette-Radoux, Susan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [40] The Prognostic Significance of Axillary Lymph Node Ratio in Stage II/III Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
    Kong, Amanda
    Kelley, Katherine
    Sparapani, Rodney
    Yen, Tina
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : 70 - 71